877 related articles for article (PubMed ID: 35011044)
1. Gut Microbiota and Complications of Type-2 Diabetes.
Iatcu CO; Steen A; Covasa M
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011044
[TBL] [Abstract][Full Text] [Related]
2. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.
Zhou Z; Sun B; Yu D; Zhu C
Front Cell Infect Microbiol; 2022; 12():834485. PubMed ID: 35242721
[TBL] [Abstract][Full Text] [Related]
3. Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM).
Tanase DM; Gosav EM; Neculae E; Costea CF; Ciocoiu M; Hurjui LL; Tarniceriu CC; Maranduca MA; Lacatusu CM; Floria M; Serban IL
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276482
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus.
Duan L; An X; Zhang Y; Jin D; Zhao S; Zhou R; Duan Y; Zhang Y; Liu X; Lian F
Biomed Pharmacother; 2021 Oct; 142():112094. PubMed ID: 34449321
[TBL] [Abstract][Full Text] [Related]
5. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes.
Huda MN; Kim M; Bennett BJ
Front Endocrinol (Lausanne); 2021; 12():632335. PubMed ID: 33897618
[TBL] [Abstract][Full Text] [Related]
6. From role of gut microbiota to microbial-based therapies in type 2-diabetes.
Ebrahimzadeh Leylabadlo H; Sanaie S; Sadeghpour Heravi F; Ahmadian Z; Ghotaslou R
Infect Genet Evol; 2020 Jul; 81():104268. PubMed ID: 32126303
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic methods of gut microbiota modification in colorectal cancer management - fecal microbiota transplantation, prebiotics, probiotics, and synbiotics.
Kaźmierczak-Siedlecka K; Daca A; Fic M; van de Wetering T; Folwarski M; Makarewicz W
Gut Microbes; 2020 Nov; 11(6):1518-1530. PubMed ID: 32453670
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Significance of Gut Microbiota in Diabetes Pathogenesis and Management-A Narrative Review.
Młynarska E; Wasiak J; Gajewska A; Steć G; Jasińska J; Rysz J; Franczyk B
Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931292
[TBL] [Abstract][Full Text] [Related]
9. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
Yurtdaş G; Akdevelioğlu Y
J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
[TBL] [Abstract][Full Text] [Related]
10. Targeting gut microbiota as a possible therapy for diabetes.
He C; Shan Y; Song W
Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
[TBL] [Abstract][Full Text] [Related]
11. Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy.
Fernandes R; Viana SD; Nunes S; Reis F
Biochim Biophys Acta Mol Basis Dis; 2019 Jul; 1865(7):1876-1897. PubMed ID: 30287404
[TBL] [Abstract][Full Text] [Related]
12. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.
Barengolts E
Endocr Pract; 2016 Oct; 22(10):1224-1234. PubMed ID: 27409822
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiome and Its Impact on Obesity and Obesity-Related Disorders.
Sankararaman S; Noriega K; Velayuthan S; Sferra T; Martindale R
Curr Gastroenterol Rep; 2023 Feb; 25(2):31-44. PubMed ID: 36469257
[TBL] [Abstract][Full Text] [Related]
14. The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis.
Bock PM; Telo GH; Ramalho R; Sbaraini M; Leivas G; Martins AF; Schaan BD
Diabetologia; 2021 Jan; 64(1):26-41. PubMed ID: 33047170
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota and type 2 diabetes mellitus.
Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
[TBL] [Abstract][Full Text] [Related]
16. Rebuilding the Gut Microbiota Ecosystem.
Gagliardi A; Totino V; Cacciotti F; Iebba V; Neroni B; Bonfiglio G; Trancassini M; Passariello C; Pantanella F; Schippa S
Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30087270
[TBL] [Abstract][Full Text] [Related]
17. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
[TBL] [Abstract][Full Text] [Related]
18. Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation.
Su L; Hong Z; Zhou T; Jian Y; Xu M; Zhang X; Zhu X; Wang J
Sci Rep; 2022 Jan; 12(1):1152. PubMed ID: 35064189
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiome a promising target for management of respiratory diseases.
Trivedi R; Barve K
Biochem J; 2020 Jul; 477(14):2679-2696. PubMed ID: 32726437
[TBL] [Abstract][Full Text] [Related]
20. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
Halmos T; Suba I
Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]